Bradley S. Mayhew
Attorney at Law
Registered Patent Attorney

Admittance
Supreme Court of Indiana
U.S. District Court, Northern District of Indiana
U.S. District Court, Southern District of Indiana
U.S. Patent & Trademark Office

Education
Indiana University Robert H. McKinney School of Law, J.D.
Indiana University School of Medicine, M.S., Pharmacology
Wabash College, A.B., Biology
 

Bradley Mayhew is a licensed attorney and is registered to practice before the U.S. Patent & Trademark Office. His primary focus is the preparation and prosecution of patent applications drawn to inventions in the areas of biotechnology, pharmacology and chemistry.

Brad has significant work experience in the field of Intellectual Property. Prior to founding Mayhew Law, Brad worked as a Patent Agent at the law firm of Sidley Austin Brown & Wood, where he conducted research in support of patent litigation as well as patent infringement and freedom-to-operate opinions. Brad also worked as an Intellectual Property Manager at Medimmune where he assessed the potential value and patentability of inventions, coordinated with inventors and external counsel to direct patent prosecution, and monitored competitive intellectual property developments. In addition, Brad served for three years as a Patent Examiner at the U.S. Patent & Trademark Office where he examined cases in the area of complex biotechnology.

Brad has extensive knowledge of subjects relevant to the biotechnology and pharmaceutical industries. He performed and published research in the fields of enzymology and drug metabolism as a researcher in the Department of Medicine at the Indiana University School of Medicine. He also earned a graduate degree from the school's Department of Pharmacology where his studies included courses in pharmacology, physiology, medicinal chemistry, bio-organic chemistry, biophysics, biochemistry and physical biochemistry. Brad additionally holds an undergraduate degree in biology with an emphasis in molecular genetics and a minor in chemistry.

Prior to graduate study, Brad worked in Japan as an editor in the Research Planning Department of Sankyo Co., Ltd., a major Japanese pharmaceutical company. His work involved editing and rewriting manuscripts from diverse fields including chemistry, analytical chemistry, biochemistry, pharmacology, toxicology and clinical medicine. The experience provided a unique insight into the mechanisms for research and development conducted in the pharmaceutical industry.


Prior Employment
 
Sidley Austin Brown & Wood LLP, Washington, DC
Patent Agent
 
Medimmune, Inc., Gaithersburg, MD
Intellectual Property Manager
 
U.S. Patent & Trademark Office, Arlington, VA
Patent Examiner
 
Indiana University School of Medicine, Indianapolis, IN
Research Analyst
 
Sankyo Co., Ltd., Tokyo, Japan
Technical Editor
 

Memberships
 
American Bar Association, Intellectual Property Law  (ABA-IPL)
American Intellectual Property Law Association  (AIPLA)
Association of University Technology Managers  (AUTM)
Patent & Trademark Office Society  (PTOS)
National Association of Patent Practitioners  (NAPP)
International Society for the Study of Xenobiotics  (ISSX)
Phi Delta Phi  (ΦΔΦ)
 

Publications
 
Mayhew BS, Jones DR, and Hall SD
"An In Vitro Model for Predicting In Vivo Inhibition of Cytochromes P450 Resulting from Metabolic-Intermediate Complex Formation" Drug Metabolism and Disposition, 2000, vol. 28, no. 9, pages 1031-1037
pdf
 
 
Jones DR, Gorski JC, Hamman MA, Mayhew BS, Rider S, and Hall SD
"Diltiazem Inhibition of CYP3A Activity is Due to Metabolite Intermediate Complex Formation"  Journal of Pharmacology and Experimental Therapeutics, 1999, vol. 290, no. 3, pages 1116-1125
 
Hall SD, Mayhew BS, Gorski JC, and Jones DR
"Principles of In Vitro Studies: Enzyme Kinetics, Inhibition and Induction" in  Drug-Drug Interactions: Analyzing In Vitro-In Vivo Correlations, IBC USA, Inc., 1996
 
Mayhew BS, Jones DR, Gorski JC, and Hall SD
"Non-Hyperbolic Interactions Between Substrates of Cytochrome P450 (CYP) 3A4" Midwest Cytochrome P450 Symposium, 1996
 
Mayhew BS, Gorski JC, and Hall SD
"Midazolam Hydroxylation Reveals the Potential for Non-Hyperbolic Kinetics in Cytochrome P450 (CYP) 3A4"
ISSX Proceedings, 1995, vol. 8, page 3